MCCP
PMVP icon

Mission Creek Capital Partners’s PMV Pharmaceuticals PMVP Stock Holding History

Mission Creek Capital Partners’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23,077
Closed -$759K – 239
2021
Q1 		$759K Buy
+23,077
New +$910K 0.11% 126

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mission Creek Capital Partners's PMVP Position: Q2 2021 in Review

Mission Creek Capital Partners sold out of PMV Pharmaceuticals (PMVP) in Q2 2021, closing a stake of 23,077 shares — an estimated $759K sold.

Mission Creek Capital Partners first reported a position in PMVP in Q1 2021 and held it in 1 quarter. The position peaked at $759K in Q1 2021. 85 funds tracked by Wall St. Rank hold PMVP as of Q2 2021.

  • Mission Creek Capital Partners reported no remaining PMV Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Mission Creek Capital Partners sold 23,077 PMV Pharmaceuticals shares in Q2 2021, an estimated $759K.
  • Mission Creek Capital Partners first reported a position in PMV Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Mission Creek Capital Partners's PMV Pharmaceuticals position peaked at $759K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2021.

Based on Mission Creek Capital Partners's 13F filing for Q2 2021, filed 13 Aug 2021.